Aetna modified CPB 1045 for osseointegration surgery, effective January 22, 2026. The policy classifies all osseointegration procedures as experimental — and your billing team needs to understand exactly what that means before submitting a single claim.
Aetna updated CPB 1045 to reinforce that osseointegration surgery remains classified as experimental, investigational, or unproven. The update embeds strict Standard Written Order requirements and tightens documentation standards for durable medical equipment suppliers billing under this policy. If your practice or DME supplier submits claims for limb osseointegration — or if you're billing HCPCS L5991 — this policy change affects your reimbursement directly.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Osseointegration for Lower and Upper Limbs |
| Policy Code | CPB 1045 |
| Change Type | Modified |
| Effective Date | January 22, 2026 |
| Impact Level | High |
| Specialties Affected | Orthopedic Surgery, Prosthetics & Orthotics, Physical Medicine & Rehabilitation, DME Suppliers |
| Key Action | Understand that osseointegration surgery is non-covered under this policy — and that SWO requirements apply to DME billing generally, not as a path to reimbursement |
Aetna Osseointegration Coverage Criteria and Medical Necessity Requirements 2026
The Aetna osseointegration coverage policy under CPB 1045 makes one thing clear from the start: Aetna does not cover osseointegration surgery. The policy classifies it as experimental, investigational, or unproven. That includes the OPRA Implant System (Osseoanchored Prostheses for the Rehabilitation of Amputees) and the Axor II connection device.
This isn't a close call or a gray area. Aetna says the effectiveness of osseointegration surgery has not been established. Until that changes, the procedure itself isn't covered.
Where this policy gets operationally important is the billing guidelines on the DME side. Aetna has embedded DME MAC policy standards into CPB 1045 verbatim. Medical necessity must be supported by information in the member's medical record. Supplier-prepared statements and physician attestations alone are not sufficient — even when signed by the ordering physician. This is the same standard the Medicare Administrative Contractor applies to DME claims, and Aetna applies it equally here.
The coverage policy also draws a hard line on who qualifies as a "treating practitioner." A prosthetist, orthotist, orthotic fitter, pedorthotist, physical therapist, or occupational therapist does not qualify. Only a physician (MD or DO), physician assistant, nurse practitioner, or clinical nurse specialist can serve as the treating practitioner for purposes of this policy.
That distinction matters for your SWO. If the order doesn't come from a qualified treating practitioner, the claim will be denied.
Aetna Osseointegration Exclusions and Non-Covered Indications
Osseointegration surgery for upper and lower limb amputees is the primary non-covered service under CPB 1045. Aetna's position is unambiguous: the surgery itself, and the prosthetic system attached to it, are experimental.
This applies specifically to the OPRA Implant System and the Axor II connection device. If your patient's surgeon is using one of these systems, the procedure is not covered under Aetna's policy as of January 22, 2026.
One clarification worth noting: the policy does not apply to osseointegrated devices used for hearing — brainstem auditory devices, osseointegrated implants to the mastoid process of the temporal bone, and auditory brainstem devices are all excluded from the scope of CPB 1045. Those are governed by separate policies. Don't conflate the two when you're reviewing claims or responding to denials.
The real issue here is that patients pursuing osseointegration for limb loss are often well-informed and highly motivated. They may present with surgeon letters, clinical study references, and strong advocacy from their prosthetist. None of that changes Aetna's position under this policy. If you're in a patient-facing billing role, prepare your team to explain this clearly — and document those conversations.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Osseointegration surgery for upper or lower limb amputees | Not Covered (Experimental) | L5991 | Includes OPRA Implant System and Axor II device |
| OPRA Implant System specifically | Not Covered (Experimental) | L5991 | Named explicitly in CPB 1045 |
| Axor II connection device | Not Covered (Experimental) | L5991 | Named explicitly in CPB 1045 |
| Osseointegrated hearing devices (auditory brainstem, mastoid) | Out of Scope | — | Not governed by CPB 1045; see separate policies |
Aetna Osseointegration Billing Guidelines and Action Items 2026
The billing guidelines embedded in this policy are specific and enforceable. These are compliance standards for DME billing generally — they do not create a reimbursement pathway for a procedure Aetna classifies as experimental. Here's what your team needs to do before submitting any claim that touches CPB 1045.
| # | Action Item |
|---|---|
| 1 | Flag all L5991 claims for pre-submission review. HCPCS L5991 — the osseointegrated external prosthetic connector addition to lower extremity prostheses — is the primary code affected by this policy. Every claim for L5991 on an Aetna patient should trigger a documentation review before submission. The underlying procedure category is non-covered. Treat any L5991 claim on an Aetna patient as high-risk regardless of documentation quality. |
| 2 | Build a compliant Standard Written Order checklist. The SWO must be complete before the supplier bills. It needs the member's name or ID, order date, a general description of the item (HCPCS code, code narrative, or brand/model), each separately billed option or accessory listed individually, each item's HCPCS code and quantity, the treating practitioner's name and NPI, and the treating practitioner's signature. Missing any element means claim denial. |
| 3 | Verify treating practitioner credentials before processing the SWO. The order must come from a physician (MD or DO), PA, NP, or CNS. If the order comes from a prosthetist, physical therapist, or orthotist, it does not qualify. Send it back before it goes to the supplier. |
| 4 | Pull the medical record to support medical necessity — don't rely on attestations. Aetna explicitly follows DME MAC policy here: supplier-prepared statements and physician attestations are not sufficient on their own. Your documentation needs chart notes, clinical findings, and records that independently support the claim. If the only documentation is an attestation from a provider with a financial interest in the claim, expect denial. |
| 5 | Get a new prescription each time a new device or repair is ordered. Aetna requires a new prescription from the treating practitioner for each new device or repair. A standing order or blanket authorization doesn't cover subsequent events. Build this into your ordering workflow now. |
| 6 | Educate your DME suppliers on the SWO timing requirement. The SWO must be communicated to the supplier before the claim is submitted. This seems obvious, but in practice, suppliers sometimes receive incomplete orders and submit anyway. That's a claim denial waiting to happen. If you work with external DME suppliers, send them this policy update before the next claim cycle. |
| 7 | Understand that the experimental classification drives coverage, not documentation. Because osseointegration surgery is experimental under this policy, no documentation package changes that status. If a patient or provider is pushing for coverage of the surgery itself, your answer needs to reflect CPB 1045's position clearly. Direct them to the policy. If you're fielding appeals on this, loop in your compliance officer before responding. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Osseointegration Under CPB 1045
HCPCS Codes — Osseointegration
| Code | Type | Description | Status |
|---|---|---|---|
| L5991 | HCPCS | Addition to lower extremity prostheses, osseointegrated external prosthetic connector | Experimental/Non-Covered; underlying procedure category is not covered under CPB 1045 |
Key ICD-10-CM Diagnosis Codes
| Code | Description |
|---|---|
| Z47.81 | Encounter for orthopedic aftercare following surgical amputation |
| Z89.9 | Acquired absence of limb, unspecified |
A note on these codes: Z47.81 and Z89.9 appear in the CPB 1045 policy. Neither code by itself triggers coverage — Aetna's experimental classification applies to the procedure and device category regardless of diagnosis.
There are no covered CPT codes under this policy. The policy does not list specific CPT codes for the surgery itself, which aligns with the experimental classification — Aetna has not established a covered procedure pathway for osseointegration surgery. HCPCS L5991 is the only code addressed, and it sits squarely in a non-covered category: the code exists, but the underlying procedure it supports is experimental under CPB 1045.
This is worth flagging for your charge capture team. The billing guidelines under CPB 1045 mean that any claim for L5991 on an Aetna patient carries significant denial risk. Treat every instance as requiring meticulous compliance review — not as routine billing.
Related Aetna Policies Your Billing Team Should Know
Aetna's CPB 1045 cross-references CPB 0578, which governs lower limb prostheses. If your team bills for lower limb prosthetics broadly, CPB 0578 is the companion policy that addresses covered prosthetic devices. The distinction matters: standard lower limb prostheses follow a different coverage path than osseointegrated systems.
Don't assume a denial on L5991 under CPB 1045 means all lower limb prosthetic billing is at risk. Review CPB 0578 separately for your non-osseointegrated prosthetic claims.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.